In multiple tumor types, notably BRCA, HNSC, and glioma, HNRNPC emerged as the most broadly and abundantly expressed regulator across malignant and immune cells, consistent with its known role in m6A-mediated alternative splicing and RNA maturation. This evidence concerns the gene HNRNPC and central nervous system cancer.